Brexanolone is a new type of drug for the treatment of postpartum depression.

Brexanolone is a kind of progesterone with hypnotic and sedative effects, which can relieve postpartum anxiety and depression.

Recently, the U.S. Food and Drug Administration (FDA) approved brexanolone to treat postpartum depression. This medicine is used to treat postpartum depression indications.